Item Details
Skip Navigation Links
   ActiveUsers:3542Hits:25717244Skip Navigation Links
Show My Basket
Contact Us
IDSA Web Site
Ask Us
Today's News
HelpExpand Help
Advanced search

In Basket
  Journal Article   Journal Article
 

ID110293
Title ProperFDI flows into the Indian pharmaceutical industry
Other Title Informationan analysis of trends and constraints
LanguageENG
AuthorTripathy, Ishita G ;  Yadav, Surendra S ;  Sharma, Seema
Publication2011.
Summary / Abstract (Note) India's economic reforms since 1990s and World Trade Organisation's Agreement on Trade-Related Aspects of Intellectual Property Rights have caused significant changes in the operational environment of the Indian pharmaceutical industry (IPI). In this backdrop, this study examines the Foreign Direct Investment (FDI) flows into the firms of IPI. It finds that the amount of FDI, the number of FDI recipient firms and the number of source countries of FDI are larger during the product patent regime as compared to the process patent regime. The factor analysis of primary data presents the perception of 64 sample firms of IPI as regards the main constraints of FDI inflows in the product patent regime.
`In' analytical NoteJournal of Intellectual Property Rights Vol. 16, No. 4; Jul 2011: p330-334
Journal SourceJournal of Intellectual Property Rights Vol. 16, No. 4; Jul 2011: p330-334
Key WordsIndian Pharmaceutical Industry ;  FDI ;  Patent Regime ;  India ;  Economic Reform